Calretinin mediates apoptosis in small cell lung cancer cells expressing tetraspanin CD9

被引:1
|
作者
He, Ping [1 ,3 ]
Kuhara, Hanako [1 ]
Tachibana, Isao [1 ]
Jin, Yingji [1 ]
Takeda, Yoshito [1 ]
Tetsumoto, Satoshi [1 ]
Minami, Toshiyuki [1 ]
Kohmo, Satoshi [1 ]
Hirata, Haruhiko [1 ]
Takahashi, Ryo [1 ]
Inoue, Koji [1 ]
Nagatomo, Izumi [1 ]
Kida, Hiroshi [1 ]
Kijima, Takashi [1 ]
Naka, Tetsuji [1 ,4 ]
Morii, Eiichi [2 ]
Kawase, Ichiro [1 ]
Kumanogoh, Atsushi [1 ,5 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan
[3] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 2, Dept Resp Med, Xian 71004, Peoples R China
[4] Natl Inst Biomed Innovat, Lab Immune Signal, Osaka 5670085, Japan
[5] Osaka Univ, WPI Immunol Frontier Res Ctr, Dept Immunopathol, CREST,JST, Suita, Osaka 5650871, Japan
来源
FEBS OPEN BIO | 2013年 / 3卷
关键词
Small cell lung cancer; Proteomics; Tetraspanin; CD9; Calretinin; Apoptosis; PROTEINS;
D O I
10.1016/j.fob.2013.04.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A majority of small cell lung cancer (SCLC) cells lack a metastasis suppressor, tetraspanin CD9, and CD9 expression promotes their apoptosis. By a proteomics-based approach, we compared an SCLC cell line with its CD9 transfectant and found that a calcium-binding neuronal protein, calretinin, is upregulated in CD9-positive SCLC cells, Ectopic or anticancer drug-induced CD9 expression upregulated calretinin, whereas CD9 knockdown down-regulated calretinin in SCLC cells. When calretinin was knocked down, CD9-positive SCLC cells revealed increased Akt phosphorylation and decreased apoptosis. These results suggest that CD9 positively regulates the expression of calretinin that mediates proapoptotic effect in SCLC cells. (C) 2013 The Authors. Published by Elsevier B.V. on behalf of Federation of European Biochemical Societies. All rights reserved.
引用
收藏
页码:225 / 230
页数:6
相关论文
共 50 条
  • [1] Cell Surface Tetraspanin CD9 Mediates Chemoresistance in Small Cell Lung Cancer
    Kohmo, Satoshi
    Kijima, Takashi
    Otani, Yasushi
    Mori, Masahide
    Minami, Toshiyuki
    Takahashi, Ryo
    Nagatomo, Izumi
    Takeda, Yoshito
    Kida, Hiroshi
    Goya, Sho
    Yoshida, Mitsuhiro
    Kumagai, Toru
    Tachibana, Isao
    Yokota, Soichiro
    Kawase, Ichiro
    [J]. CANCER RESEARCH, 2010, 70 (20) : 8025 - 8035
  • [2] Tetraspanin CD9 in cell migration
    Powner, Dale
    Kopp, Petra M.
    Monkley, Susan J.
    Critchley, David R.
    Berditchevski, Fedor
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2011, 39 : 563 - 567
  • [3] CD9, a tetraspanin target for cancer therapy?
    Lorico, Aurelio
    Lorico-Rappa, Marco
    Karbanova, Jana
    Corbeil, Denis
    Pizzorno, Giuseppe
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 246 (09) : 1121 - 1138
  • [4] THE TETRASPANIN CD9 IS A CELL-ADHESION MOLECULE
    CROSSNO, JT
    WHITE, MM
    WILKINSON, DA
    JENNINGS, LK
    [J]. FASEB JOURNAL, 1995, 9 (06): : A1377 - A1377
  • [5] The tetraspanin CD9 is a negative regulator of EGF receptor signaling in cancer cells
    Murayama, Yoko
    Shinomura, Yasuhisa
    Tamura, Shinji
    Hayashi, Norio
    [J]. GASTROENTEROLOGY, 2006, 130 (04) : A674 - A674
  • [6] Tetraspanin CD9 determines invasiveness and tumorigenicity of human breast cancer cells
    Rappa, Germana
    Green, Toni M.
    Karbanova, Jana
    Corbeil, Denis
    Lorico, Aurelio
    [J]. ONCOTARGET, 2015, 6 (10) : 7970 - 7991
  • [7] A peptide binding to the tetraspanin CD9 reduces cancer metastasis
    Suwatthanarak, Thanawat
    Ito, Kazuma
    Tanaka, Masayoshi
    Sugiura, Kei
    Hoshino, Ayuko
    Miyamoto, Yoshitaka
    Miyado, Kenji
    Okochi, Mina
    [J]. BIOMATERIALS ADVANCES, 2023, 146
  • [8] Prognostic value and multifaceted roles of tetraspanin CD9 in cancer
    Ondrussek, Robert
    Kvokackova, Barbora
    Krystofova, Karolina
    Brychtova, Svetlana
    Soucek, Karel
    Bouchal, Jan
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Tetraspanin CD9: A friend or foe of head and neck cancer
    Suhasini, P. C.
    Shetty, Shilpa S.
    Nalilu, Suchetha Kumari
    Shetty, Praveen Kumar
    Patil, Prakash
    [J]. ONCOLOGY REPORTS, 2022, 47 (05)
  • [10] Tetraspanin CD9 contributes to cell fusion during osteoclastogenesis
    Saeki, Y
    Iwai, KKI
    Ishii, MMI
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 125 - 125